Genetics
The obesity revolution: will new drugs bring about big changes?
The recent approval of the obesity and diabetes drugs Wegovy, Ozempic, and Mounjaro has brought about big headlines, but are […] June 21, 2023 · V-Bio Ventures
Fundamental research leads to treatment breakthrough in rare genetic diseases
A basic research breakthrough is improving patient lives, as researchers realized their rare genetic condition could be treated by repurposing […] June 8, 2020 · BioVox
Can Darwin’s theory explain why we get sick?
While physicians care for their individual patients and are interested in the factors contributing to the individual’s condition, evolutionary biologists […] September 30, 2020 · V-Bio Ventures
A life-changing discovery: CRISPR scientists awarded the 2020 Nobel Prize in Chemistry
After several years of nominations, Emmanuelle Charpentier and Jennifer Doudna have finally been awarded the 2020 Nobel Prize in Chemistry […] November 4, 2020 · BioVoxeTheRNA and China Grand Pharma enter a strategic collaboration in the Greater China Region focussed on eTheRNA’s proprietary mRNA development products and manufacturing capabilities
Niel, Belgium, 1 December 2020 – eTheRNA immunotherapies NV (“eTheRNA”) announced it has entered into a strategic cooperation and product […] December 2, 2020 · Quality by Design - Business & Communications
Prestigious prize for Belgian breakthrough in brain research
Prof. Dr. Pierre Vanderhaeghen from VIB-KU Leuven has been awarded the Generet Prize for Rare Diseases for his research on […] January 27, 2021 · BioVox
Saving man’s best friend: Volition blood test allows cheap and easy cancer screenings for dogs
A Belgian invention is revolutionizing cancer diagnostics for dogs by making it possible to screen for two common canine cancers […] March 10, 2021 · BioVox
Beer, bread and bioethanol: SUPERYEAST project to improve industry sustainability
Prof. Kevin Verstrepen, of the VIB-KU Leuven Center for Microbiology, has received a prestigious ERC Proof of Concept grant for […] April 28, 2021 · BioVoxDroia Ventures raises a new fund of EUR 220 million to target genetic diseases and expands leadership team with George Golumbeski
Brussels, Belgium, 11 May 2021 – Droia Ventures today announced the final closing of its third fund, having raised EUR […] May 11, 2021 · Quality by Design - Business & CommunicationsNewton Biocapital invests in EditForce to support development of a unique DNA/RNA editing platform based on PPR protein technology
Brussels, Belgium / Tokyo, Japan – 1 July 2021 – Newton Biocapital (“Newton”), a life sciences investment fund active in […] July 1, 2021 · Quality by Design - Business & Communications
Betting on the best egg: Aurora test doubles pregnancy chances in assisted conception
Assisted conception techniques have matured in the last few decades, with Belgian scientists playing a big part in the progress. […] August 18, 2021 · BioVox
The dark matter of the genome: Flamingo Therapeutics taps potential of mysterious RNA for cancer therapies
Things are moving fast for Flamingo Therapeutics, a Leuven-based biotech company developing innovative RNA-targeted cancer therapies. The start-up is a […] October 20, 2021 · BioVox
New GMOs on the horizon: say ‘cheese’!
To meet the challenges of climate change and global food demand, more VCs are investing in AgTech companies. A lot […] October 20, 2021 · V-Bio Ventures